Devacell, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Devacell, Inc.
Quantité totale PI 9
Rang # Quantité totale PI 180 245
Note d'activité PI 1,5/5.0    5
Rang # Activité PI 202 909
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

4 1
0 0
4 0
0
 
Dernier brevet 2024 - Recombinant oncolytic viruses, s...
Premier brevet 2014 - Enzyme-encapsulated nanoparticle...
Dernière marque 2017 - ONCOAT
Première marque 2017 - ONCOAT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2021 Invention Recombinant oncolytic viruses, surface-engineered delivery systems and related methods. Provided...
Invention Recombinant oncolytic viruses, surface-engineered delivery systems and related methods. Provided ...
Invention Recombinant viruses, surface-engineered delivery systems and related methods. Provided herein ar...
Invention Recombinant viruses, surface-engineered delivery systems and related methods. Provided herein are...
2017 P/S Medical research and development services, namely, developing cancer treatments by applying coati...
2014 Invention Enzyme-encapsulated nanoparticle platform. Disclosed are methods, systems, and devices for implem...